Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gupta

Showing results (291-300 of 314) with videos related to

Pageof 32
Sort By:
Journal of the American College of Radiology : JACR|November 6, 2020
ACR Appropriateness Criteria® Indeterminate Renal Mass, Zhen J Wang, Paul Nikolaidis, et al.
Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.
The Prostate|March 10, 2023
Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored studyYu G Tan, Yan M Law, Nye T Ngo, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 21, 2015
Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencingKonstantinos Tsioris, Namita T Gupta, Adebola O Ogunniyi, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path ForwardL C Harshman, C G Drake, N B Haas, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Hematuria, Darcy J Wolfman, Jamie Marko, et al.
Cancer Medicine|March 2, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew L Laccetti, Benjamin Garmezy, Lianchun Xiao, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinomaLandon C Brown, Jason Zhu, Kunal Desai, et al.
Clinical and Experimental Immunology|August 1, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitisS C Sasson, J J Zaunders, K Nahar, et al.
Journal of the American College of Radiology : JACR|November 19, 2021
ACR Appropriateness Criteria® Adrenal Mass Evaluation: 2021 Update, Rekha N Mody, Erick M Remer, et al.
Pageof 32

Showing results (291-300 of 314) with videos related to

Sort By:
Pageof 32
Journal of the American College of Radiology : JACR|November 6, 2020
ACR Appropriateness Criteria® Indeterminate Renal Mass, Zhen J Wang, Paul Nikolaidis, et al.
Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.
The Prostate|March 10, 2023
Patient-reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy-monitored studyYu G Tan, Yan M Law, Nye T Ngo, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 21, 2015
Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencingKonstantinos Tsioris, Namita T Gupta, Adebola O Ogunniyi, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path ForwardL C Harshman, C G Drake, N B Haas, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Hematuria, Darcy J Wolfman, Jamie Marko, et al.
Cancer Medicine|March 2, 2021
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomesAndrew L Laccetti, Benjamin Garmezy, Lianchun Xiao, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinomaLandon C Brown, Jason Zhu, Kunal Desai, et al.
Clinical and Experimental Immunology|August 1, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitisS C Sasson, J J Zaunders, K Nahar, et al.
Journal of the American College of Radiology : JACR|November 19, 2021
ACR Appropriateness Criteria® Adrenal Mass Evaluation: 2021 Update, Rekha N Mody, Erick M Remer, et al.
Pageof 32